Stockreport

TherapeuticsMD Announces the FDA has Granted AnnoveraTM Marketing Exclusivity as a New Chemical Entity

TherapeuticsMD, Inc.  (TXMD) 
NASDAQ:AMEX Investor Relations: ir.therapeuticsmd.com
PDF BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced that AnnoveraTM (segeste [Read more]